3-Piperidinylmethyl benzoate hydrochloride
|
- $45 - $446
- Product name: 3-Piperidinylmethyl benzoate hydrochloride
- CAS: 1219972-66-3
- MF: C13H18ClNO2
- MW: 255.74
- EINECS:
- MDL Number:MFCD13559844
- Synonyms:3-Piperidinylmethyl benzoate hydrochloride;PIPERIDIN-3-YLMETHYL BENZOATE HYDROCHLORIDE
5 prices
Selected condition：
Brand
- Crysdot
- Matrix Scientific
- TRC
Package
- 5mg
- 10mg
- 500mg
- 2.500g
- 5g
- ManufacturerCrysdot
- Product numberCD11326273
- Product descriptionPiperidin-3-ylmethylbenzoatehydrochloride 95+%
- Packaging5g
- Price$446
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number049361
- Product description3-Piperidinylmethyl benzoate hydrochloride
- Packaging500mg
- Price$108
- Updated2021-12-16
- Buy
- ManufacturerMatrix Scientific
- Product number049361
- Product description3-Piperidinylmethyl benzoate hydrochloride
- Packaging2.500g
- Price$293
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP992793
- Product description3-PiperidinylmethylbenzoateHydrochloride
- Packaging5mg
- Price$45
- Updated2021-12-16
- Buy
- ManufacturerTRC
- Product numberP992793
- Product description3-PiperidinylmethylbenzoateHydrochloride
- Packaging10mg
- Price$60
- Updated2021-12-16
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Crysdot | CD11326273 | Piperidin-3-ylmethylbenzoatehydrochloride 95+% | 5g | $446 | 2021-12-16 | Buy |
| Matrix Scientific | 049361 | 3-Piperidinylmethyl benzoate hydrochloride | 500mg | $108 | 2021-12-16 | Buy |
| Matrix Scientific | 049361 | 3-Piperidinylmethyl benzoate hydrochloride | 2.500g | $293 | 2021-12-16 | Buy |
| TRC | P992793 | 3-PiperidinylmethylbenzoateHydrochloride | 5mg | $45 | 2021-12-16 | Buy |
| TRC | P992793 | 3-PiperidinylmethylbenzoateHydrochloride | 10mg | $60 | 2021-12-16 | Buy |
Properties
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|